Despite these differences, convergent functional outcomes have been reported, such as restoration of follicle numbers, normalization of estrous cyclicity and hormone profiles, reduced granulosa cell apoptosis, and improved ovarian architecture, frequently associated with activation of pathways including PI3K/AKT or SMAD signaling (He et al., 2024, Huang et al., 2018, Yang et al., 2019)
That would likely result in lawsuits from the industry, says Abha Kundi, an attorney at ArentFox Schiff who focuses on FDA regulatory law
Those are substantial numbers for an 8-week trial
August 17, 2023
How Clinicians Can Integrate GHK-Cu Into Their Aesthetic Practice So, what are GHK-Cu peptides used for